Prevention of post-ERCP pancreatitis

Minerva Med. 2014 Apr;105(2):129-36.

Abstract

Over the last 10-15 years there have been refinements in the understanding of risk factors for development of acute post-ERCP pancreatitis (PEP). These risk factors can be divided into patient risks and procedural risks. The most basic way to prevent PEP is avoidance of purely diagnostic ERCP and low-probability ERCP for bile duct stones by use of non-invasive or less-invasive imaging procedures. Improvement in cannulation techniques has led to a reduction in PEP. Placement of prophylactic pancreatic stents and, more recently, use of rectally administered non-steroidal anti-inflammatory agents (NSAIDs) has further reduced the risk of PEP in high-risk patients and/or following high-risk procedures. In this review the methods for prevention of PEP will be discussed.

Publication types

  • Review

MeSH terms

  • Administration, Rectal
  • Age Factors
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Catheterization / adverse effects
  • Catheterization / methods
  • Cholangiopancreatography, Endoscopic Retrograde / adverse effects*
  • Cholangiopancreatography, Endoscopic Retrograde / methods
  • Fluid Therapy / methods
  • Humans
  • Pancreatitis / diagnostic imaging
  • Pancreatitis / etiology
  • Pancreatitis / prevention & control*
  • Risk Factors
  • Sex Factors
  • Stents
  • Tomography, X-Ray Computed

Substances

  • Anti-Inflammatory Agents, Non-Steroidal